Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Dec 14;313(7071):1552–1553. doi: 10.1136/bmj.313.7071.1552c

Adverse events associated with mefloquine. Women may be more susceptible to adverse events.

M Phillips
PMCID: PMC2353079  PMID: 8978256

Full text

PDF
1552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett P. J., Emmins P. D., Clarke P. D., Bradley D. J. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ. 1996 Aug 31;313(7056):525–528. doi: 10.1136/bmj.313.7056.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Phillips MA, Kass RB. User Acceptability Patterns for Mefloquine and Doxycycline Malaria Chemoprophylaxis. J Travel Med. 1996 Mar 1;3(1):40–45. doi: 10.1111/j.1708-8305.1996.tb00695.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES